— Know what they know.
Not Investment Advice
Also trades as: LALPATHLAB.BO (BSE) · $vol 1M

LALPATHLAB.NS NSE

Dr. Lal PathLabs Limited
1W: +5.3% 1M: +17.2% 3M: +20.5% YTD: +15.7% 1Y: -29.3% 3Y: -9.3% 5Y: -40.6%
₹1,626.40 ($17.00)
-54.40 (-3.24%)
 
Weekly Expected Move ±8.9%
₹1300 ₹1441 ₹1583 ₹1724 ₹1865
NSE · Healthcare · Medical - Diagnostics & Research · Alpha Radar Strong Buy · Power 65 · ₹272.2B mcap · 150M float · 0.334% daily turnover
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market Cap₹272.2B ($2.8B)
52W Range1272.6-1770
Volume194,061
Avg Volume500,659
Beta0.11
Dividend₹13.00
Analyst Ratings
No analyst coverage
Company Info
CEOShankha Banerjee
Employees4,099
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2015-12-23
Tower B, SAS Tower
Gurugram 122001
IN
91 12 4301 6500
About Dr. Lal PathLabs Limited

Dr. Lal PathLabs Limited provides diagnostic and related healthcare tests and services in India and internationally. It operates laboratories for carrying the pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The company also offers lab staff training; technical; and lab management services. As of March 31, 2022, the company had 277 clinical laboratories, including National Reference Lab at Delhi and Regional Reference Lab at Kolkata; and 4,731 patient service centers and 10,599 pick-up points. Dr. Lal PathLabs Limited was founded in 1949 and is based in Gurugram, India.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms